Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 86451-86500 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT05384626
A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
PHASE1/PHASE2Recruiting
840 participants
Started: Jun 9, 2022 · Completed: Jan 31, 2028
2 conditions1 sponsor74 locations
NCT04894370
Combination of Spartalizumab, mDCF and Radiotherapy in Patients With Metastatic Squamous Cell Anal Carcinoma
PHASE2Recruiting
34 participants
Started: Jun 9, 2022 · Completed: Nov 1, 2026
2 conditions3 sponsors5 locations
NCT05156710
BIVV020 (SAR445088) n Prevention and Treatment of Antibody-mediated Rejection (AMR)
PHASE2Active, not recruiting
48 participants
Started: Jun 9, 2022 · Completed: Nov 17, 2026
1 condition1 sponsor27 locations
NCT05162781
Transferring Speed of Processing Gains to Everyday Cognitive Tasks After Stroke
NARecruiting
82 participants
Started: Jun 9, 2022 · Completed: Dec 31, 2026
2 conditions3 sponsors1 location
NCT05377684
Study of Quality of Life and Hormone Levels in Premenopausal Participants With Early Breast Cancer Receiving Triptorelin Plus Additional Cancer Treatment
N/AActive, not recruiting
450 participants
Started: Jun 9, 2022 · Completed: Jun 30, 2026
1 condition1 sponsor22 locations
NCT05347225
A Study of Nemtabrutinib (MK-1026) in China Participants With Relapsed or Refractory Hematologic Malignancies (MK-1026-005)
PHASE1Active, not recruiting
12 participants
Started: Jun 9, 2022 · Completed: Apr 30, 2027
1 condition1 sponsor5 locations
NCT05186740
ProVee Urethral Expander System IDE Study (ProVIDE)
NAActive, not recruiting
221 participants
Started: Jun 9, 2022 · Completed: Dec 31, 2028
1 condition1 sponsor17 locations
NCT05280509
Study of TL-895 Combined With Ruxolitinib in JAKi Treatment-Naïve MF Subjects and Subjects With MF Who Have a Suboptimal Response to Ruxolitinib
PHASE1/PHASE2Recruiting
70 participants
Started: Jun 9, 2022 · Completed: Apr 30, 2027
4 conditions1 sponsor19 locations
NCT06577896
The Study to Evaluate the Safety and Efficacy of the Onyx Family
N/ARecruiting
500 participants
Started: Jun 9, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT06998108
Study of BEBT-209 in Combination With Fulvestrant Versus Placebo in Combination With Fulvestrant in Patients With HR+/HER2- Locally Advanced or Metastatic Breast Cancer Who Have Progressed After Prior Endocrine Therapy
PHASE3Recruiting
330 participants
Started: Jun 9, 2022 · Completed: Jun 30, 2026
1 condition2 sponsors1 location
NCT05684042
Fracture Registry University Hospital Basel
N/ARecruiting
216 participants
Started: Jun 9, 2022 · Completed: Jun 30, 2033
1 condition1 sponsor1 location
NCT06152536
Effect of a Vegetarian Meal on the Physiology of Insulin Response in Patients With Type 2 Diabetes Mellitus and Obesity
NARecruiting
20 participants
Started: Jun 9, 2022 · Completed: Sep 30, 2024
4 conditions1 sponsor1 location
NCT05655793
The TearAD Study: Tear Biomarkers for Alzheimer's Disease (AD) Screening and Diagnosis
N/ARecruiting
200 participants
Started: Jun 9, 2022 · Completed: Jul 1, 2025
1 condition1 sponsor2 locations
NCT05421455
Surgery Versus Biologics for Stricturing CD--a RCT
NARecruiting
138 participants
Started: Jun 9, 2022 · Completed: Jun 30, 2030
1 condition1 sponsor1 location
NCT05375344
Mobility and Voiding Exercises in Older Women With Urinary Incontinence (MoVEonUp)
NARecruiting
375 participants
Started: Jun 9, 2022 · Completed: Aug 31, 2026
1 condition1 sponsor1 location
NCT05285735
Observational Study of the Safety of Intravenous Artesunate Treatment of Pregnant Women and Their Infants
N/ARecruiting
25 participants
Started: Jun 8, 2022 · Completed: Jul 1, 2029
2 conditions1 sponsor1 location
NCT06701240
Evaluating a Strengths-based Community-grounded Intervention
NAActive, not recruiting
199 participants
Started: Jun 8, 2022 · Completed: Aug 31, 2027
4 conditions1 sponsor1 location
NCT05797714
The Effectiveness and Safety of TMF in the Treatment of Chronic Hepatitis B Patients With Normal ALT.
NAActive, not recruiting
200 participants
Started: Jun 8, 2022 · Completed: Apr 15, 2026
2 conditions2 sponsors12 locations
NCT05438459
GAIA-102 Intraperitoneal Administration in Patients With Advanced Gastrointestinal Cancer of Microsatellite Stable With Malignant Ascites
PHASE1/PHASE2Recruiting
96 participants
Started: Jun 8, 2022 · Completed: Jun 8, 2027
2 conditions8 sponsors1 location
NCT05482126
Sensory Filtering in the Human Basal Ganglia as a Mechanism of Parkinson's Disease
N/ARecruiting
30 participants
Started: Jun 8, 2022 · Completed: Sep 30, 2026
1 condition2 sponsors1 location
NCT05382559
A Study of ASP3082 in Adults With Advanced Solid Tumors
PHASE1Recruiting
651 participants
Started: Jun 8, 2022 · Completed: Oct 31, 2026
1 condition1 sponsor49 locations
NCT05144256
A Study to Evaluate the Efficacy and Safety of Mitapivat in Pediatric Participants With Pyruvate Kinase Deficiency (PKD) Who Are Regularly Transfused, Followed by a 5-Year Extension Period
PHASE3Active, not recruiting
49 participants
Started: Jun 8, 2022 · Completed: Jun 30, 2029
2 conditions1 sponsor22 locations
NCT07172009
The Effect of Chlorhexidine Mouthwash on Postprandial Glucose Response in Healthy Individuals
NARecruiting
45 participants
Started: Jun 8, 2022 · Completed: Jun 1, 2026
1 condition1 sponsor1 location
NCT05913427
Evaluation of the Efficacy of Addition of Progesterone to Standard Chemotherapy in Adrenocortical Carcinoma (ACC)
PHASE2Recruiting
80 participants
Started: Jun 8, 2022 · Completed: Jun 8, 2027
1 condition1 sponsor1 location
NCT05214651
A Clinical Research on Repair of Massive-large Rotator Cuff Tears
NARecruiting
52 participants
Started: Jun 8, 2022 · Completed: May 31, 2026
1 condition1 sponsor1 location
NCT05481502
An Exploratory Study to Evaluate Immune Determinants of the Response to Adoptive Cell Therapy (ACT) in Solid and Hematologic Tumors
NARecruiting
160 participants
Started: Jun 8, 2022 · Completed: Jul 1, 2027
3 conditions1 sponsor1 location
NCT05291273
Influence of Anthropometric Data, Shoulder Complex Muscle Strength, and Abdominal-lumbar Endurance in Closed Kinetic Chain Upper Extremity Stability Test
NARecruiting
247 participants
Started: Jun 8, 2022 · Completed: Dec 8, 2025
1 condition1 sponsor1 location
NCT05365815
Melanated Group Midwifery Care (MGMC)
NARecruiting
432 participants
Started: Jun 8, 2022 · Completed: Feb 1, 2027
3 conditions3 sponsors1 location
NCT05359263
Effects of Dapagliflozin on EChOcardiographic Measures of CarDiac StructurE and Function in Patients with CKD
PHASE2Recruiting
222 participants
Started: Jun 8, 2022 · Completed: Feb 18, 2025
1 condition1 sponsor1 location
NCT05351593
Tafasitamab Plus Lenalidomide in Relapsed CNS Lymphoma
PHASE1/PHASE2Recruiting
35 participants
Started: Jun 8, 2022 · Completed: Jun 30, 2026
3 conditions2 sponsors1 location
NCT05526417
Individualized Prehabilitation for Enhancing Recovery and Surgical Outcomes in Patients Undergoing Radiotherapy and Surgery for Soft Tissue Sarcoma
NARecruiting
30 participants
Started: Jun 8, 2022 · Completed: Jun 8, 2026
4 conditions1 sponsor1 location
NCT05080998
Longitudinal Bladder Cancer Study for Tumour Recurrence
N/ARecruiting
450 participants
Started: Jun 8, 2022 · Completed: Aug 31, 2026
1 condition1 sponsor7 locations
NCT05382728
Phase III Study of TY-9591 in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer (FLETEO)
PHASE3Recruiting
680 participants
Started: Jun 8, 2022 · Completed: Dec 31, 2027
2 conditions1 sponsor2 locations
NCT05397769
Envafolimab Plus Chemoradiotherapy for Locally Advanced NPC, a Prospective, Single Armed Phase II Trial.
PHASE2Recruiting
36 participants
Started: Jun 8, 2022 · Completed: Dec 31, 2026
4 conditions1 sponsor1 location
NCT05208944
THIO Sequenced With Cemiplimab in Advanced NSCLC
PHASE2Recruiting
227 participants
Started: Jun 8, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor33 locations
NCT05345899
Evaluation of Plasma Vitamin C Levels in a Population of Chronic Rheumatism in Immuno-Rheumatology
NARecruiting
200 participants
Started: Jun 8, 2022 · Completed: Dec 31, 2024
2 conditions1 sponsor1 location
NCT05005299
Venetoclax in Combination With Non-myeloablative Conditioning Allogeneic Haematopoietic Stem Cell Transplantation
PHASE1Recruiting
18 participants
Started: Jun 8, 2022 · Completed: Mar 31, 2026
6 conditions1 sponsor1 location
NCT05462379
Autologous Heterotopic Fresh Ovarian Graft in Woman With LACC Eligible for Pelvic Radiotherapy Treatment.
PHASE1/PHASE2Active, not recruiting
22 participants
Started: Jun 8, 2022 · Completed: Apr 1, 2027
2 conditions1 sponsor1 location
NCT05969314
To Check Safety of Ayurvedic Oral Cannabis in Breast and Head and Neck Cancer
PHASE1Active, not recruiting
12 participants
Started: Jun 8, 2022 · Completed: Jun 30, 2025
2 conditions1 sponsor2 locations
NCT05794048
METabolic PROFILE of Hepatocarcinoma and Pancreatic Tumors
NARecruiting
300 participants
Started: Jun 8, 2022 · Completed: Sep 8, 2026
2 conditions1 sponsor1 location
NCT05550675
Prospective Database of Factors Associated with Faecal Vs. Double Incontinence in Patients Referred for High Resolution Anorectal Manometry.
N/ARecruiting
150 participants
Started: Jun 8, 2022 · Completed: Jul 31, 2030
3 conditions1 sponsor1 location
NCT05385796
STEP Trial for Heel Fat Pad Syndrome
NARecruiting
19 participants
Started: Jun 8, 2022 · Completed: Feb 29, 2024
1 condition2 sponsors1 location
NCT05384444
Effect of FMD on Colorectal Cancer Patients
NARecruiting
602 participants
Started: Jun 8, 2022 · Completed: Oct 30, 2025
2 conditions7 sponsors6 locations
NCT05321706
DAPAgliflozin for Renal Protection in Heart Transplant Recipients
PHASE3Recruiting
430 participants
Started: Jun 8, 2022 · Completed: May 31, 2028
2 conditions6 sponsors6 locations
NCT06282549
Study to Evaluate the Efficacy and Safety of TEL/AML/CTD in Elderly Patients with Essential Hypertension
N/AActive, not recruiting
1,219 participants
Started: Jun 8, 2022 · Completed: Mar 31, 2027
1 condition1 sponsor5 locations
NCT05446389
PAL to Improve Oral Feeding for Infants With Chronic Lung Disease
NARecruiting
60 participants
Started: Jun 8, 2022 · Completed: Dec 31, 2026
4 conditions2 sponsors1 location
NCT04971772
SIGNATURE Study : DCB (Legflow) vs POBA in Fempop Arteries
N/ARecruiting
148 participants
Started: Jun 8, 2022 · Completed: May 31, 2026
3 conditions2 sponsors6 locations
NCT05395481
A Single-Ascending and Repeated Dose Study of LY3849891 in Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
PHASE1Recruiting
176 participants
Started: Jun 8, 2022 · Completed: Oct 31, 2026
2 conditions1 sponsor16 locations
NCT05096351
Immunological Reaction of the Recipient After Cold-stored Saphenous Venous Allograft (Bioprotec)
N/ARecruiting
50 participants
Started: Jun 8, 2022 · Completed: Dec 31, 2025
3 conditions1 sponsor1 location
NCT05453409
Study on Clinical Features, Treatment Mode and Survival of Sarcoma
N/ARecruiting
6,000 participants
Started: Jun 7, 2022 · Completed: Dec 31, 2024
1 condition1 sponsor1 location